2,992
Views
15
CrossRef citations to date
0
Altmetric
Research Articles

Development, optimization, and evaluation of a nanostructured lipid carrier of sesame oil loaded with miconazole for the treatment of oral candidiasis

ORCID Icon, ORCID Icon, , , , , , , , , , & show all
Pages 254-262 | Received 19 Oct 2021, Accepted 20 Dec 2021, Published online: 11 Jan 2022

References

  • Aljaeid BM, Hosny KM. (2016). Miconazole-loaded solid lipid nanoparticles: formulation and evaluation of a novel formula with high bioavailability and antifungal activity. Int J Nanomedicine 11:441–7.
  • Alkhalidi HM, Hosny KM, Rizg WY. (2021). Oral gel loaded by fluconazole-sesame oil nanotransfersomes: development, optimization, and assessment of antifungal activity. Pharmaceutics 13:1–23.
  • Al-Yahya AAI, Asad M. (2016). Antiulcer activity of gum Arabic and its interaction with antiulcer effect of ranitidine in rats. Biomed Res 27:1102–6.
  • Choudhury H, Pandey M, Yin TH, et al. (2019). Rising horizon in circumventing multidrug resistance in chemotherapy with nanotechnology. Mater Sci Eng C 101:596–613.
  • Gheorghe DC, Niculescu AG, Bîrcă AC, Grumezescu AM. (2021). Biomaterials for the prevention of oral candidiasis development. Pharmaceutics 13:803–18.
  • Hermawan D, Suwandri U, Sulaeman A, Istiqomah HY. (2017). Development of high performance liquid chromatography method for miconazole analysis in powder sample. IOP Conf Ser Mater Sci Eng 172:1–6.
  • Hosny KM, Bahmdan RH, Alhakamy NA, et al. (2020). Physically optimized nano-lipid carriers augment raloxifene and vitamin D oral bioavailability in healthy humans for management of osteoporosis. J Pharm Sci 109:2145–55.,.
  • Imran M, Iqubal MK, Imtiyaz K, et al. (2020). Topical nanostructured lipid carrier gel of quercetin and resveratrol: formulation, optimization, in vitro and ex vivo study for the treatment of skin cancer. Int J Pharm 587:119705.
  • Iqubal MK, Iqubal A, Imtiyaz K, et al. (2021). Combinatorial lipid-nanosystem for dermal delivery of 5-fluorouracil and resveratrol against skin cancer: delineation of improved dermatokinetics and epidermal drug deposition enhancement analysis. Eur J Pharm Biopharm 163:223–39.
  • Lavaee F, Moshaverinia M, MalekHosseini SA, et al. (2019). Antifungal effect of sesame medicinal herb on Candida species: original study and mini-review. Brazilian J Pharm Sci 55:1–6.
  • Marwah H, Garg T, Rath G, Goyal AK. (2016). Development of transferosomal gel for trans-dermal delivery of insulin using iodine complex. Drug Deliv 23:1636–44.
  • Matos BN, Pereira MN, de Bravo MO, et al. (2020). Chitosan nanoparticles loading oxaliplatin as a mucoadhesive topical treatment of oral tumors: iontophoresis further enhances drug delivery ex vivo. Int J Biol Macromol 154:1265–75.
  • Mendes AI, Silva AC, Catita JAM, et al. (2013). Miconazole-loaded nanostructured lipid carriers (NLC) for local delivery to the oral mucosa: improving antifungal activity. Colloids Surfaces B Biointerfaces 111:755–63.
  • Mostofa R, Ahmed S, Begum MM, et al. (2017). Evaluation of anti-inflammatory and gastric anti-ulcer activity of Phyllanthus niruri L. (Euphorbiaceae) leaves in experimental rats. BMC Complement Altern Med 17:1–10.
  • Mussi SV, Sawant R, Perche F, et al. (2014). Novel nanostructured lipid carrier co-loaded with doxorubicin and docosahexaenoic acid demonstrates enhanced in vitro activity and overcomes drug resistance in MCF-7/Adr cells. Pharm Res 31:1882–92.
  • Ogawa T, Nishio J, Okada S. (2014). Effect of edible sesame oil on growth of clinical isolates of Candida albicans. Biol Res Nurs 16:335–43.
  • Opatha SAT, Titapiwatanakun V, Chutoprapat R. (2020). Transfersomes: a promising nanoencapsulation technique for transdermal drug delivery. Pharmaceutics 12:855–23.
  • Patil S, Rao RS, Majumdar B, Anil S. (2015). Clinical appearance of oral Candida infection and therapeutic strategies. Front Microbiol 6:1391–10.
  • Pinto S, Pintado ME, Sarmento B. (2020). In vivo, ex vivo and in vitro assessment of buccal permeation of drugs from delivery systems. Expert Opin Drug Deliv 17:33–48.
  • Rençber S, Karavana SY, Yılmaz FF, et al. (2016). Development, characterization, and in vivo assessment of mucoadhesive nanoparticles containing fluconazole for the local treatment of oral candidiasis. Int J Nanomedicine 11:2641–53.
  • Santiago RR, Gyselle de Holanda e Silva K, Dantas dos Santos N, et al. (2018). Nanostructured lipid carriers containing amphotericin B: development, in vitro release assay, and storage stability. J Drug Deliv Sci Technol 48:372–82.
  • Serrano J, López-Pintor R-M, Ramírez L, et al. (2020). Risk factors related to oral candidiasis in patients with primary Sjögren’s syndrome. Med Oral Patol Oral Cir Bucal 25:e700–5.
  • Talapko J, Juzbašić M, Matijević T, et al. (2021). Candida albicans-the virulence factors and clinical manifestations of infection. JoF 7:79.
  • Vila T, Sultan AS, Montelongo-Jauregui D, Jabra-Rizk MA. (2020). Oral Candidiasis: a disease of opportunity. J Fungi 6:15.
  • Zhang L-W, Fu J-Y, Hua H, Yan Z-M. (2016). Efficacy and safety of miconazole for oral candidiasis: a systematic review and meta-analysis. Oral Dis 22:185–95.